Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study

(2014) A.J. Kanwar et al.   BRITISH JOURNAL OF DERMATOLOGY

An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab

(2014) K.T. Amber et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

The Cost-Effectiveness of a Pharmacogenetic Test: A Trial-Based Evaluation of TPMT Genotyping for Azathioprine

(2014) Alexander J. Thompson et al.   VALUE IN HEALTH

Laboratory diagnosis of paraneoplastic pemphigus

(2013) A.M. Poot et al.   BRITISH JOURNAL OF DERMATOLOGY

Recommandations des centres de référence des maladies bulleuses auto-immunes pour le diagnostic et la prise en charge du pemphigus

(2011) P. Joly et al.   ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

British Association of Dermatologists’ guidelines for the safe and effective prescribing of azathioprine 2011

(2011) S.J. Meggitt et al.   BRITISH JOURNAL OF DERMATOLOGY

Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients

(2011) M. Kasperkiewicz et al.   BRITISH JOURNAL OF DERMATOLOGY

Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris

(2011) M. Behzad et al.   BRITISH JOURNAL OF DERMATOLOGY

Low-dose rituximab is effective in pemphigus

(2011) B. Horváth et al.   BRITISH JOURNAL OF DERMATOLOGY

Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis)

(2011) Pascal Joly et al.   CLINICS IN DERMATOLOGY

A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus

(2011) Linda K. Martin et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study

(2011) D. Ioannides et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Treating Pemphigus Vulgaris with Prednisone and Mycophenolate Mofetil: A Multicenter, Randomized, Placebo-Controlled Trial

(2010) Stefan Beissert et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

A randomized double-blind trial of intravenous immunoglobulin for pemphigus

(2009) Masayuki Amagai et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Multicenter Randomized, Double-blind, Placebo-Controlled, Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance-Phase Pemphigus Vulgaris

(2008) Victoria P. Werth et al.   ARCHIVES OF DERMATOLOGY

Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases

(2008) Michael Hertl et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

(2008) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY